GSE197532 GSE197533 adenosine 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE197532_GSE197533_adenosine_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE197532_GSE197533_adenosine_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE197532_GSE197533_adenosine_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE197532_GSE197533_adenosine_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

VPS9D1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 667

Gene

family with sequence similarity 174 member C

Gene

ILF3 divergent transcript

Gene

RNF32 divergent transcript

Gene

PHLDA1 antisense RNA 1

Gene

A2M antisense RNA 1

Gene

uncharacterized LOC100287036

Gene

WASIR family lncRNA 2

Gene

coiled-coil domain-containing protein 144A-like

  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 667


  • Gene

    family with sequence similarity 174 member C


  • Gene

    ILF3 divergent transcript


  • Gene

    RNF32 divergent transcript


  • Gene

    PHLDA1 antisense RNA 1


  • Gene

    A2M antisense RNA 1


  • Gene

    uncharacterized LOC100287036


  • Gene

    WASIR family lncRNA 2


  • Gene

    coiled-coil domain-containing protein 144A-like

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.